<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T23:10:23Z</responseDate>
  <request identifier="oai:figshare.com:article/32633352" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32633352</identifier>
        <datestamp>2026-10-01T17:04:01Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>QUB-1942: a bioactive peptide from Phyllomedusa hypochodrialis skin secretion</dc:title>
          <dc:creator>Jin Han (9149)</dc:creator>
          <dc:subject>PUREID: 365374941</dc:subject>
          <dc:subject>Antimicrobial peptides</dc:subject>
          <dc:subject>phyllomedusa hypochondrialis</dc:subject>
          <dc:subject>phylloseptin</dc:subject>
          <dc:subject>antibacterial</dc:subject>
          <dc:subject>anticancer</dc:subject>
          <dc:description>Antimicrobial peptides, separated and identified from frog and toad skin secretions, have been studied for years. In this thesis, QUB-1942, a peptide belonging to the phylloseptin family, was derived from the skin secretion of the orange-legged leaf frog, Phyllomedusa hypochondrialis. The peptide sequence was obtained through ‘shotgun’ cloning by constructing a cDNA library using frog skin secretion isolated mRNA. The peptide was then synthesised by solid-phase peptide synthesis, purified by reversed-phase high-performance liquid chromatography, and structural-confirmed by matrix-assisted, laser desorption, ionisation, time-of-flight mass spectrometry. In bioassays, QUB-1942 showed inhibitory effects on the Gram-positive bacterium, Staphylococcus aureus (S. aureus ATCC CRM6538)at a concentration from 2 μM, the Gram-negative bacterium, Escherichia coli (E. coli ATCC CRM8739) at a concentration from 8 μM, and the yeast, Candida albicans (C. albicans ATCC CRM10231) at a concentration 64 μM. The minimum inhibitory concentration (MIC) value of the three microbes are 4 μM , 8 μM, 64 μM, respectively. In terms of MTT anticancer cell proliferation assay, QUB-1942 was proven to have anti-proliferative activity against a human lung cancer cell line (H838) in a range of concentrations from 10-6 M to 10-4 M. The trypan blue exclusion assay confirmed the killing effect of the peptide on H838 cells. However, QUB-1942 had a haemolytic effect higher than 20% on horse red blood cells when the concentration was higher than 64 μM. In conclusion, QUB-1942 has potential to become a safe antimicrobial and anticancer drug in the future after its haemolytic toxicity at high concentrations can be substantially decreased through structural modification.&lt;br&gt;&lt;br&gt;&lt;i&gt;Thesis embargoed until 31 December 2027&lt;/i&gt;</dc:description>
          <dc:date>2026-10-01T17:04:01Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32633352.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/QUB-1942_a_bioactive_peptide_from_Phyllomedusa_hypochodrialis_skin_secretion/32633352</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
          <dc:rights>Open Access after 2027-12-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
